RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Female Sexual Dysfunction Therapy Area Pipeline Report
Nov 2010 - 76 pages - $1,495
Male Sexual Dysfunction - Pipeline Review, Q4 2010
Dec 2010 - 36 pages - $500
Female Sexual Dysfunction - Pipeline Review, Q1 2011
Mar 2011 - 49 pages - $500
Female Sexual Dysfunction - Pipeline Review, H2 2011
Oct 2011 - 73 pages - $500
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
CNS Market Access in India: Government investment into CNS services set to stimulate market growth
Jun 2011 - 99 pages - $5,700
CNS Biomarkers: Players, products and prospects (Volume II)
Aug 2008 - 110 pages - $1,040
Rexahn Pharmaceuticals, Inc. (RNN) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $250
Male Sexual Dysfunction - Pipeline Review, H2 2011
Aug 2011 - 137 pages - $500
More Related Market Research Reports >>>

Your selection

Therapeutic target
Central Nervous System del
CNS (other) del
Sexual dysfunction del
Year
1999 del

Browse By

Industry sector
Academic/Research
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Non-profit org./Government
Pharmaceutical
Research tools
Service

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us